Economic evaluation of neoadjuvant chemotherapy for operable breast cancer.

被引：0
|
作者：
Zdenkowski, Nicholas
D'Silva, Shefi Mary
Lawson, Kenny
Reeves, Penny
Boyle, Frances M.
机构：
[1] Univ Newcastle, Callaghan, NSW, Australia
[2] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Mater Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12637
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dose-dense neoadjuvant chemotherapy in breast cancer.
    Catane, R
    Kaufman, B
    Zach, L
    Wolf, I
    Gluck, I
    Modiano, T
    Barsuk, D
    Shabtai, M
    Papa, M
    Paluch-Shimon, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 79S - 79S
  • [32] Nivolumab with chemotherapy as neoadjuvant treatment for inflammatory breast cancer.
    Kwa, Maryann J.
    Novik, Yelena
    Speyer, James L.
    Snuderl, Matija
    Cotzia, Paolo
    Miller, Kathy
    Newton, Erin V.
    Oratz, Ruth
    Meyers, Marleen Iva
    Schnabel, Freya Ruth
    Axelrod, Deborah M.
    Joseph, Kathie-Ann P.
    Hiotis, Karen
    Troxel, Andrea
    Mccoy, Sabrina
    Schneider, Robert
    Adams, Sylvia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Array CGH analysisin neoadjuvant chemotherapy for breast cancer.
    Kim, JY
    Kwak, H
    Choi, KU
    Chung, J
    Bae, YT
    Lee, MK
    Kim, HW
    Park, DY
    Lee, CH
    Huh, KY
    Sol, MY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 74S - 74S
  • [34] Early operable breast cancer.
    Wolff A.C.
    Davidson N.E.
    Current Treatment Options in Oncology, 2000, 1 (3) : 210 - 220
  • [35] Effect of breast conservation following neoadjuvant chemotherapy vs mastectomy with adjuvant chemotherapy in operable breast cancer
    Orozco, Javier
    Nelson, Daniel
    Chang, Shu-Ching
    Goldfarb, Melanie
    Holmes, Dennis
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 341 - 342
  • [36] Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experience
    Abdel-Bary, N.
    El-Kased, A. F.
    Aiad, H. A. Z.
    ECANCERMEDICALSCIENCE, 2009, 3
  • [37] Neoadjuvant chemotherpay for operable breast cancer
    Green, M
    Hortobagyi, GN
    ONCOLOGY-NEW YORK, 2002, 16 (07): : 871 - +
  • [38] Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients
    Omarini, C.
    Guaitoli, G.
    Noventa, S.
    Andreotti, A.
    Gambini, A.
    Palma, E.
    Papi, S.
    Tazzioli, G.
    Balduzzi, S.
    Dominici, M.
    Cascinu, S.
    Piacentini, F.
    EJSO, 2017, 43 (04): : 613 - 618
  • [39] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    CANCER RESEARCH, 2011, 71
  • [40] Prognostic factors in patients with operable breast cancer who received neoadjuvant chemotherapy
    Horiguchi, J.
    Takata, D.
    Nagaoka, R.
    Fujii, T.
    Sato, A.
    Tokiniwa, H.
    Higuchi, T.
    Uchida, S.
    Tsuboi, M.
    Yajima, R.
    Kikuchi, M.
    Ino, Y.
    Oyama, T.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S94 - S94
12345